Read More

Bio-Rad And Nuprobe Enter Into An Exclusive Licensing Agreement For Digital PCR Applications; Nuprobe USA To Exclusively License Its Allele Enrichment Technologies To Co For Development Of Multiplexed Digital PCR Assays

Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostic products, and NuProbe USA, a genomics and molecular diagnostics company, today announced the signing of a licensing

BIO